Fusarium keratitis: Genotyping, in vitro susceptibility and clinical outcomes

Cornea

Volumn 32, Issue 5, 2013, Pages 667-673

  Oechsler, Rafael A ^a,b   Feilmeier, Michael R ^a   Miller, Darlene ^a   Shi, Wei ^a   Hofling Lima, Ana Luisa ^b   Alfonso, Eduardo C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antifungal; clinical outcomes; Fusarium sp; genotyping; keratitis

Indexed keywords

AMPHOTERICIN B; CEFAZOLIN; FLUCONAZOLE; MOXIFLOXACIN; NATAMYCIN; TOBRAMYCIN; VALACICLOVIR; VORICONAZOLE;

ADULT; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; DNA SEQUENCE; FEMALE; FOLLOW UP; FUSARIUM SOLANI; GENOTYPE; HUMAN; IN VITRO STUDY; KERATOMYCOSIS; MALE; MEDICAL RECORD REVIEW; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISUAL ACUITY;

ADULT; ANTIFUNGAL AGENTS; AQUEOUS HUMOR; CORNEAL ULCER; DNA, FUNGAL; DNA, RIBOSOMAL; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIOSIS; FUSARIUM; GENOTYPING TECHNIQUES; HUMANS; KERATOPLASTY, PENETRATING; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 84876280951     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318277ac74     Document Type: Article

References (46)

1. Xie L, Hu J, Shi W. Treatment failure after lamellar keratoplasty for fungal keratitis. Ophthalmology. 2008;115:33-36. (Pubitemid 350309418)
2. Whitcher JP, Srinivasan M, Upadhyay MP. Corneal blindness: a global perspective. Bull World Health Organ. 2001;79:214-221. (Pubitemid 32246479)
3. Xie L, Zhong W, Shi W, et al. Spectrum of fungal keratitis in north China. Ophthalmology. 2006;113:1943-1948. (Pubitemid 44635704)
4. Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology. 1994;101:1005-1013. (Pubitemid 24183155)
5. Godoy P, Cano J, Gene J, et al. Genotyping of 44 isolates of Fusarium solani, the main agent of fungal keratitis in Brazil. J Clin Microbiol. 2004;42:4494-4497. (Pubitemid 39362361)
6. Chowdhary A, Singh K. Spectrum of fungal keratitis in North India. Cornea. 2005;24:8-15. (Pubitemid 40053489)
7. Garg P, Gopinathan U, Choudhary K, et al. Keratomycosis: clinical and microbiologic experience with dematiaceous fungi. Ophthalmology. 2000;107:574-580. (Pubitemid 30191381)
8. Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010;117:2263-2267.
9. Pérez-Balbuena AL, Vanzzini-Rosano V, Valadéz-Virgen Jde J, et al. Fusarium keratitis in Mexico. Cornea. 2009;28:626-630.
10. Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea. 2000;19: 307-312. (Pubitemid 30322454)
11. Hofling-Lima AL, Forseto A, Duprat JP, et al. Laboratory study of the mycotic infectious eye diseases and factors associated with keratitis. Arq Bras Oftalmol. 2005;68:21-27. (Pubitemid 41702396)
12. Jurkunas U, Behlau I, Colby K. Fungal keratitis: changing pathogens and risk factors. Cornea. 2009;28:638-643.
13. Wykoff CC, Flynn HW Jr, Miller D, et al. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology. 2008; 115:1501-1507.
14. O'Donnell K, Sarver BA, Brandt M, et al. Phylogenetic diversity and microsphere array-based genotyping of human pathogenic Fusaria, including isolates from the multistate contact lens-associated U.S. keratitis outbreaks of 2005 and 2006. J Clin Microbiol. 2007;45:2235-2248. (Pubitemid 47203799)
15. Oechsler RA, Feilmeier MR, Ledee D, et al. Utility of molecular sequence analysis of the ITS rRNA region for identification of Fusarium spp from ocular sources. Invest Ophthalmol Vis Sci. 2009;50:2230-2236.
16. Hsiao CR, Huang L, Bouchara JP, et al. Identification of medically important molds by an oligonucleotide array. J Clin Microbiol. 2005; 43:3760-3768. (Pubitemid 41129657)
17. Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006; 296:953-963. (Pubitemid 44285372)
18. O'Donnell K, Kistler HC, Tacke BK, et al. Gene genealogies reveal global phylogeographic structure and reproductive isolation among lineages of Fusarium graminearum, the fungus causing wheat scab. Proc Natl Acad Sci USA. 2000;97:7905-7910. (Pubitemid 30460746)
19. O'Donnell K, Sutton DA, Rinaldi MG, et al. Genetic diversity of human pathogenic members of the Fusarium oxysporum complex inferred from multilocus DNA sequence data and amplified fragment length polymorphism analyses: evidence for the recent dispersion of a geographically widespread clonal lineage and nosocomial origin. J Clin Microbiol. 2004;42:5109-5120. (Pubitemid 39506218)
20. Zhang N, O'Donnell K, Sutton DA, et al. Members of the Fusarium solani species complex that cause infections in both humans and plants are common in the environment. J Clin Microbiol. 2006;44:2186-2190.
21. Alfonso EC. Genotypic identification of Fusarium species from ocular sources: comparison to morphologic classification and antifungal sensitivity testing (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106: 227-239.
22. He D, Hao J, Zhang B, et al. Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani. Invest Ophthalmol Vis Sci. 2011;52:2804-2808.
23. Arikan S, Lozano-Chiu M, Paetznick V, et al. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species. J Clin Microbiol. 1999;37:3946-3951.
24. Dotis J, Simitsopoulou M, Dalakiouridou M, et al. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus. J Antimicrob Chemother. 2008;61:810-817. (Pubitemid 351426064)
25. Lewis RE, Wiederhold NP, Klepser ME. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp. Antimicrob Agents Chemother. 2005;49:945-951. (Pubitemid 40327708)
26. Azor M, Gene J, Cano J, et al. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother. 2007;51:1500-1503. (Pubitemid 46586837)
27. O'Donnell K, Sutton DA, Fothergill A, et al. Molecular phylogenetic diversity, multilocus haplotype nomenclature, and in vitro antifungal resistance within the Fusarium solani species complex. J Clin Microbiol. 2008;46:2477-2490.
28. Alfonso EC, Cantu-Dibildox J, Munir WM, et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol. 2006; 124:941-947. (Pubitemid 44036316)
29. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol. 1980;90:38-47. (Pubitemid 10033930)
30. Scott IU, Schein OD, West S, et al. Functional status and quality of life measurement among ophthalmic patients. Arch Ophthalmol. 1994;112: 329-335. (Pubitemid 24085141)
31. Mayayo E, Pujol I, Guarro J. Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol. 1999;48: 363-366. (Pubitemid 29478863)
32. Zhang S, Ahearn DG, Stulting RD, et al. Differences among strains of the Fusarium oxysporum-F. solani complexes in their penetration of hydrogel contact lenses and subsequent susceptibility to multipurpose contact lens disinfection solutions. Cornea. 2007;26:1249-1254. (Pubitemid 350190919)
33. Hua X, Yuan X, Di Pietro A, et al. The molecular pathogenicity of Fusarium keratitis: a fungal transcriptional regulator promotes hyphal penetration of the cornea. Cornea. 2010;29:1440-1444.
34. Vasanthi M, Prajna NV, Lalitha P, et al. A pilot study on the infiltrating cells and cytokine levels in the tear of fungal keratitis patients. Indian J Ophthalmol. 2007;55:27-31. (Pubitemid 46065929)
35. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia. 2001;150:101-115. (Pubitemid 32623880)
36. Pradhan L, Sharma S, Nalamada S, et al. Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol. 2011;59:512-514.
37. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzon A, et al. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother. 2008;61:805-809. (Pubitemid 351426063)
38. Iqbal NJ, Boey A, Park BJ, et al. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Microbiol Infect Dis. 2008;62:348-350.
39. Lionakis MS, Lewis RE, Samonis G, et al. Pentamidine is active in vitro against Fusarium species. Antimicrob Agents Chemother. 2003; 47:3252-3259. (Pubitemid 37229586)
40. Tortorano AM, Prigitano A, Dho G, et al. Species distribution and in vitro antifungal susceptibility patterns of 75 clinical isolates of Fusarium spp. from northern Italy. Antimicrob Agents Chemother. 2008;52: 2683-2685. (Pubitemid 351915710)
41. Espinel-Ingroff A. In vitro activity of the new triazole voriconazole (UK-109,496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens. J Clin Microbiol. 1998;36:198-202. (Pubitemid 28047458)
42. Espinel-Ingroff A. Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol. 1998;36:2950-2956. (Pubitemid 28429420)
43. Pujol I, Guarro J, Gene J, et al. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother. 1997; 39:163-167. (Pubitemid 27116410)
44. Meletiadis J, Meis JF, Mouton JW, et al. Comparison of NCCLS and 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol. 2000;38:2949-2954. (Pubitemid 30640579)
45. Del Poeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds. Antimicrob Agents Chemother. 1997;41:1835-1836. (Pubitemid 27339900)
46. Li L, Wang Z, Li R, et al. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol. 2008;146:724-728.